0001055726-20-000004.txt : 20200116
0001055726-20-000004.hdr.sgml : 20200116
20200116160927
ACCESSION NUMBER: 0001055726-20-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200115
FILED AS OF DATE: 20200116
DATE AS OF CHANGE: 20200116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shepard Jay
CENTRAL INDEX KEY: 0001587788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14888
FILM NUMBER: 20531025
MAIL ADDRESS:
STREET 1: 15977 GRANDVIEW AVENUE
CITY: MONTE SERENO
STATE: CA
ZIP: 95030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001055726
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330969592
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584103134
MAIL ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP
DATE OF NAME CHANGE: 20050404
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP
DATE OF NAME CHANGE: 20011116
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD
DATE OF NAME CHANGE: 19980213
4
1
wf-form4_157920894919990.xml
FORM 4
X0306
4
2020-01-15
0
0001055726
INOVIO PHARMACEUTICALS, INC.
INO
0001587788
Shepard Jay
660 W. GERMANTOWN PIKE SUITE 110
PLYMOUTH MEETING
PA
19462
1
0
0
0
Restricted Stock Unit
2020-01-15
4
A
0
12821
0
A
Common Stock
12821.0
12821
D
Common Stock Option
3.35
2020-01-15
4
A
0
20000
0
A
2030-01-15
Common Stock
20000.0
20000
D
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,821 restricted stock units is as follows: 4,274 shares will vest on January 15, 2021; 4,274 shares will vest on January 15, 2022; 4,273 shares will vest on January 15, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
This grant was made pursuant to the issuer's non-employee director compensation policy.
The vesting schedule for the 20,000 options is as follows: 5,000 shares vested on January 15, 2020; 5,000 shares will vest on January 15, 2021; 5,000 shares will vest on January 15, 2022; 5,000 shares will vest on January 15, 2023.
/s/ Jay P. Shepard
2020-01-16